Exploring CDKs, Ras-ERK, and PI3K-Akt in Abnormal Signaling and Cancer. J. Can. Res. Updates [Internet]. 2022 Oct. 27 [cited 2025 Oct. 10];11:63-9. Available from: https://mail.neoplasiaresearch.com/index.php/jcru/article/view/691